| Followers | 9 |
| Posts | 3236 |
| Boards Moderated | 0 |
| Alias Born | 04/21/2025 |
Friday, July 25, 2025 3:29:05 PM
You are reiterating what I already stated... Duh.
Also, I already posted my email text a while ago, when I got it.
I have all the original emails and mega data. ..
I never said rejection or approval, I said it seems to be held up for one reason or several reasons.
Again, your questions should be directed to NWBO, that is the latest advice I got from Variations.
I have no intention of contacting the company - I have in the past and was less than impressed with the misdirection,, untruths, unprofessionalism and frankly, unsolicited investment advice. To be totally honest. I'll leave it at that.
Everyone should do their own due diligence, and this company should be more candid with shareholders. MHRA does NOT restrict sponsors from corresponding with their shareholders, that was a management choice by NWBO.
Also, I already posted my email text a while ago, when I got it.
I have all the original emails and mega data. ..
I never said rejection or approval, I said it seems to be held up for one reason or several reasons.
Again, your questions should be directed to NWBO, that is the latest advice I got from Variations.
I have no intention of contacting the company - I have in the past and was less than impressed with the misdirection,, untruths, unprofessionalism and frankly, unsolicited investment advice. To be totally honest. I'll leave it at that.
Everyone should do their own due diligence, and this company should be more candid with shareholders. MHRA does NOT restrict sponsors from corresponding with their shareholders, that was a management choice by NWBO.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
